---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-130620"
form_type: "8-K"
ticker: "ACAD"
cik: "0001070494"
company_name: "ACADIA PHARMACEUTICALS INC"
filed_at: "2025-05-29T23:59:59+00:00"
generated_at: "2026-05-20T05:25:34.791300+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Acadia shareholders elect three Class III directors, approve say-on-pay, ratify EY auditor

## Summary
- Elected Catherine Owen Adams, Laura A. Brege, and Elizabeth A. Garofalo, M.D. as Class III directors; each received >129M votes for.
- Advisory vote on named executive officer compensation approved: 142.2M for, 2.8M against, 108.8K abstain.
- Ernst & Young LLP ratified as independent auditor for FY2025: 154.5M for, 926.5K against, 35.0K abstain.
- Broker non-votes of 10.3M shares on director election and advisory compensation vote.

## SEC filing metadata
- accession: 0001193125-25-130620
- form_type: 8-K
- ticker: ACAD
- cik: 0001070494
- company_name: ACADIA PHARMACEUTICALS INC
- filed_at: 2025-05-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070494/000119312525130620/0001193125-25-130620-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070494/000119312525130620/d16794d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-130620
- JSON: https://secwatch.observer/filing/0001193125-25-130620.json
- Plain text: https://secwatch.observer/filing/0001193125-25-130620.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.